Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A standout film that's incredibly compelling, Magnus von Horn's The Girl with the Needle (available to stream on Mubi Jan. 24) has achieved an Oscar nomination for best international feature film. The ...

Interchangeable knitting needles have revolutionized knitting for everyone, from beginners to experts. These versatile needles enable you to adjust the needle ends and cables to create any size or ...

SEATTLE — The year's Alaska Airlines New Year's at the Needle fireworks and drone show was an even bigger broadcast and event to ring in 2025 than in past years. It was broadcast live in Seattle ...

In addition to Wegovy, its sister drug Ozempic, indicated for diabetes, and NVO’s oral GLP-1 agonist Rybelsus have also been selected for the negotiation round. Other drugs included in the list ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. Popular Reads Penguins' Evgeni Malkin's Stanley Cup rings found elsewhere ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Wegovy and Zepbound tipped to fuel $20B boom ... questions remain about how Novo's latest numbers can move the needle in a competitive market. The company's stock price decline of 4% on Friday ...

The New Year’s Eve fireworks show at the Space Needle has nearly become an annual exercise in futility in Seattle—and it’s time we admit it. Actually, it was time to cancel the Seattle ...

WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...

According to leading data and analytics company GlobalData, Eli Lilly’s Zepbound (tirzepatide) is poised to surpass Novo Nordisk’s Wegovy (semaglutide), despite expectations for continued ...